Autolus Therapeutics Plc ADR (AUTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 09-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -142,094 | -123,849 | N/A | -44,751 | N/A |
| Depreciation Amortization | 5,658 | 4,611 | N/A | 1,709 | 1,000 |
| Income taxes - deferred | -1,344 | -399 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,439 | -1,451 | N/A | 838 | N/A |
| Other Working Capital | 1,410 | -16,204 | N/A | 4,732 | -790 |
| Other Operating Activity | 17,173 | 35,808 | 0 | 5,935 | 3,150 |
| Operating Cash Flow | $-117,758 | $-101,484 | $N/A | $-31,537 | $3,360 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14,681 | -18,341 | N/A | -9,119 | -2,870 |
| Purchase Sale Intangibles | N/A | -327 | N/A | -412 | N/A |
| Other Investing Activity | 0 | -327 | 0 | -412 | 0 |
| Investing Cash Flow | $-14,681 | $-18,668 | $N/A | $-9,531 | $-2,870 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 80,212 | 108,863 | N/A | 156,920 | N/A |
| Other Financing Activity | -5,797 | 0 | 0 | 0 | 127,680 |
| Financing Cash Flow | $74,415 | $108,863 | $N/A | $156,920 | $127,680 |
| Exchange Rate Effect | 679 | 5,164 | N/A | -5,833 | N/A |
| Beginning Cash Position | 211,430 | 217,555 | N/A | 137,070 | N/A |
| End Cash Position | 154,085 | 211,430 | N/A | 247,089 | N/A |
| Net Cash Flow | $-57,345 | $-6,125 | $N/A | $110,019 | $128,170 |
| Free Cash Flow | |||||
| Operating Cash Flow | -117,758 | -101,484 | N/A | -31,537 | 3,360 |
| Capital Expenditure | -14,681 | -18,341 | N/A | -9,119 | N/A |
| Free Cash Flow | -132,439 | -119,825 | 0 | -40,656 | 3,360 |